Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report

Abstract Background The use of isavuconazole is approved for the management of invasive aspergillosis and mucormycosis, only in adults, as no paediatric pharmacology studies have been reported to date. Very few paediatric cases have been published concerning the use of isavuconazole. Amphotericin B...

Full description

Bibliographic Details
Main Authors: Marjorie Cornu, Bénédicte Bruno, Séverine Loridant, Pauline Navarin, Nadine François, Fanny Lanternier, Elisa Amzallag-Bellenger, François Dubos, Françoise Mazingue, Boualem Sendid
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Pharmacology and Toxicology
Subjects:
Isavuconazole
Mucormycosis
Paediatrics
Drug-monitoring
Lichtheimia
Online Access:http://link.springer.com/article/10.1186/s40360-018-0273-7

Internet

http://link.springer.com/article/10.1186/s40360-018-0273-7

Similar Items